By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Soligenix 

29 Emmons Drive
Suite C-10
Princeton  New Jersey  08540  U.S.A.
Phone: 609-538-8200 Fax: 609-452-6467


SEARCH JOBS








Company News
Soligenix (SNGX) Announces Issuance Of US Patent for ThermoVax™ Technology 9/9/2014 7:59:13 AM
Soligenix (SNGX) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City 9/8/2014 8:44:09 AM
Soligenix (SNGX) Expands Pipeline With Acquisition Of Phase 3-Ready Oncology Clinical Program 9/5/2014 10:19:35 AM
Soligenix (SNGX) Announces Positive Survival Results With Heat Stable Ricin Toxin Vaccine 9/3/2014 3:42:14 PM
Soligenix (SNGX) Reports Second Quarter 2014 Financial Results, And Highlights Recent Accomplishments 8/11/2014 8:42:53 AM
Soligenix (SNGX) Advances Development Of A Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™ 8/7/2014 8:09:53 AM
Soligenix (SNGX) Advances Development Of A Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™ 8/7/2014 8:06:42 AM
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of OrbeShield™ In GI ARS 8/1/2014 7:14:57 AM
Soligenix (SNGX) Announces Combination Vaccine For Ricin And Anthrax Achieves Simultaneous Protection 7/9/2014 10:01:59 AM
Soligenix (SNGX) Reports First Quarter 2014 Financial Results, And Highlights Recent Accomplishments 5/12/2014 6:12:35 AM
12345678910...
//-->